1. Increased mitral valve regurgitation and myocardial hypertrophy in two dogs with long-term pimobendan therapy;Tissier,2005
2. Comparative cardiac toxicity of the IV administered benzimidazole pyridazinon derivative pimobendan and its enantiomers in female Beagle dogs;Schneider,1997
3. Acute, subacute and chronic toxicity studies of pimobendan in laboratory animals;Schneider,1992
4. Hemodynamically induced heart lesions in the dog after the administration of cardio-active substances;Schneider,1990
5. 5. FDA freedom of information summary, Vetmedin, Boehringer Ingelheim Vetmedica (http://www.fda.gov/OHRMS/DOCKETS/98fr/2007-141-273-fois001).